ENACT (Expanding Nilotinib Access in Clinical Trials) study in adult patients (pts) with Imatinib-resistant or -intolerant Chronic Myeloid Leukemia (CML): Subgroup analysis of Pts from Germany, Austria and Switzerland (DACH)
- HK Al-Ali (Autor*in)
- P le Coutre (Autor*in)
- J Duyster (Autor*in)
- Werner Linkesch (Autor*in)
- D Wolf (Autor*in)
- U Schanz (Autor*in)
- GM Baerlocher (Autor*in)
- B Wackwitz (Autor*in)
- D Heim (Autor*in)
Aktivität: Vortrag oder Poster › Poster